Across TCGA pan-cancer cohorts, PCDHGA10 RNA is linked to patient survival in 27 of 34 cancer types, making it the most broadly survival-associated PCDHGA10 data layer compared with 8 for mutation status and 2 for mass-spec protein.
The strongest signal is observed in cervical squamous cell carcinoma and endocervical adenocarcinoma (CESC), where higher PCDHGA10 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated PCDHGA10 expression acts as an unfavorable survival marker, although some lineages such as KIRC and PCPG show a favorable association.
CESC, HNSC, and LUSC are the cancer types where PCDHGA10 RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.